Announcement Roche, a leading multinational healthcare giant drug investigation and efforts for early stage breast cancer has finally showed progress. Roche’s oral SERD reduced death risk by 30% in early-stage breast cancer, which is a huge milestone for the company and a valuable contributi...
Announcement Zealand, at its Capital Markets Day in London, gave an overview of its robust strategy for its weight management legacy initiatives, which will be finalised in the near term, and the five products will be launched by 2030. Alongside, Zealand Pharma also announced its partnership with C...
Announcement Amylyx Pharmaceuticals, Inc., a leading company, has showcased the presentation of early tolerability and safety data from the combined of results from the running work characterizing biomarkers of AMX0114 and its Phase 1 LUMINA trial of AMX0114, a focused deal at the 36th Internation...
Announcement Freenome Holdings, Inc., a leading early cancer detection company establishing blood-related screening tests and Perceptive Capital Solutions Corp, a known special purpose acquisition company (SPAC), presented by a subsidiary of Perceptive Advisors, have signed a definitive business me...
Announcement Eli Lilly, the leading Pharmaceutical company, has been working towards improving and developing the healthcare sector from the core for more than a decade. The company is working to enhance global patient affordability and health literacy while achieving all the sustainability goals....
Announcement The increased concern across the global healthcare sector is seeking acquisition, a strong trading business, or a valuable partnership to improve the specific regional healthcare sector. Latest, Aden Duale, a Health Cabinet Secretary, has excitingly confirmed the partnership framework...
Announcement Defence Therapeutics Inc., a leading biotechnology company modernising an exclusive intracellular delivery platform that allows more effective, safe and potent radiotherapeutic and antibody-related treatments, has introduced its new Scientific Advisory Board (SAB), involving leaders su...
Announcement PreveCeutical Medical Inc. is excited to declare its authorisation, as the Australian Patent Office has awarded Australian Patent No. AU2020212659, headlined “A Cyclic Peptide”. This headline is based on the Company’s pain therapy program. This authorisation marks a ...
Announcement The first-ever AI-familiar biotech groundbreaking large and small molecule therapeutics discovery, 1910, has proudly announced that its robust AI model, CANDID-CNS™, is now a part of the Journal of Chemical Information and Modeling (JCIM). Being published in an American Chemical ...
Announcement The Massachusetts-based Crescent Biopharma has joined forces with China’s Sichuan Kelun-Biotech to establish and advance the combined antibody-drug conjugate and PD-1/VEGF bispecific, in a collaboration valued at around $1.25 billion. Basically, it’s a swapping of therapie...
